Finapres Medical Systems

What Finapres Medical Systems does

Finapres Medical Systems B.V. is a Netherlands-based (Enschede) private medical device company that develops and distributes hardware and software for continuous non-invasive hemodynamic monitoring. Founded in 2002 as a vehicle to commercialize the Penaz volume-clamp method (1973) and the Wesseling Modelflow algorithm (1990s), the company has been an associated company of the Demcon group since 2011. Its flagship offering is the Finapres NOVA, a modular hemodynamic monitoring platform that delivers beat-to-beat blood pressure, ECG, respiration, and SpO2 from a finger cuff using the volume-clamp method, with optional software modules for Modelflow-derived cardiac output (Advanced Hemodynamics), heart rate variability and baroreflex sensitivity (Autonomic Testing), and protocol-driven autonomic function testing (Guided Autonomic Testing). Underlying technologies include NANO CORE (wrist-module servo-control miniaturization, 2016), Physiocal (automatic calibration to prevent arterial smooth muscle drift), and the Height Correction Unit (hydrostatic arm-movement compensation).

The company sells through direct sales from Enschede plus an authorized distributor network of approximately 35 partners across 26+ countries spanning Europe, North America, South America, Asia, Oceania, and Africa. Pricing is quote-based across four NOVA hardware tiers (Basic, ECG+RESP, SpO2, Full Options) and an expanding software subscription portfolio, with annual service and calibration contracts providing recurring revenue. End customers are predominantly clinical research institutions, university hospitals, and specialized research programs (including NASA, ESA, CNES, Harvard, Johns Hopkins, Mayo Clinic, University Hospital Zurich), targeting autonomic failure diagnosis, hemodynamic evaluation, physiology education, and specialized applications such as orthostatic hypotension, sleep disorders, pharmacological research, and space medicine.

Name

Finapres Medical Systems

Legal name

Finapres Medical Systems B.V.

Website

https://finapres.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Finapres Medical Systems is a Netherlands-based medical device company that develops the Finapres NOVA platform for continuous non-invasive hemodynamic monitoring using the volume-clamp method, serving clinical researchers, universities, hospitals, and space agencies across 26+ countries.

Ownership category

akta.pro rank

Product category

Hemodynamic Monitoring Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Blood Pressure Monitoring (Cuff & Cuffless) (HLAHACAC)

akta.pro secondary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

Keywords

• Non-invasive blood pressure monitoring
• Hemodynamic monitoring systems
• Autonomic function testing
• Cardiovascular measurement devices
• Medical device manufacturing

Headquarters

HQ city

Enschede

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Hardware Systems: Sale of Finapres NOVA hemodynamic monitoring systems in four hardware configurations: Basic, ECG+RESP, SpO2, and Full Options. Systems can be expanded with additional software applications and hardware configurations at any time.
2. Software Applications: Optional software applications including Guided Autonomic Testing, Advanced Hemodynamics, Autonomic Testing, NOVA Measurement Review, Remote Control, and HL7 Connect. Software can be upgraded during device lifetime with license codes.
3. Service and Support: Annual service contracts with yearly check and calibration recommended for all Finapres devices. Repair services performed in company laboratory.

Pricing tiers

Go-to-market motion2 records

Distribution channels15 records

Marketing channels7 records

Core offering

Finapres Medical Systems designs, manufactures, and sells the Finapres NOVA, a continuous non-invasive hemodynamic monitoring system that uses a finger cuff based on the proprietary volume-clamp method to deliver beat-to-beat blood pressure, hemodynamic parameters, autonomic testing, and optional ECG, respiration, and SpO2 modules. The platform is sold in four hardware configurations and extended via six software applications (Guided Autonomic Testing, Advanced Hemodynamics, Autonomic Testing, NOVA Measurement Review, Remote Control, HL7 Connect), and is backed by annual service and calibration contracts.

Product overview

Finapres Medical Systems offers a platform-based product architecture centered on the Finapres NOVA hemodynamic monitoring system. The core offering is the Finapres NOVA, an innovative hemodynamic monitoring device that provides continuous non-invasive blood pressure monitoring using a finger cuff. The platform is available in four hardware configurations (Basic, ECG+RESP, SpO2, and Full Options) and supports multiple optional software applications including Guided Autonomic Testing (GAT) for standardized autonomic function testing, Advanced Hemodynamics (HD) for 18 cardiovascular parameters via the Modelflow® algorithm, Autonomic Testing (AT) for HRV and Baroreceptor Sensitivity, NOVA Measurement Review/NOVAscope for data analysis, Remote Control software for remote operation, and HL7 Connect for hospital network integration. The system is built on core technologies including the Volume-Clamp method, NANO CORE® wrist module, Physiocal calibration algorithm, and Height Correction Unit. Finapres Medical Systems is an associated company of Demcon, based in Enschede, Netherlands, with over 30 years of research and more than 2,500 peer-reviewed publications supporting its technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Finapres NOVA Hemodynamic Monitoring System Innovative hemodynamic monitoring system providing accurate non-invasive continuous blood pressure monitoring using just a finger cuff. The Finapres NOVA comes in four hardware configurations (Basic, ECG+RESP, SpO2, Full Options) and can be expanded with additional software applications and hardware modules at any time.
• Guided Autonomic Testing (GAT) Software application that guides the operator and patient through autonomic test maneuvers including Valsalva test, Tilt Table test, Deep Breathing test, Stand test, Cold Pressor test, Carotid Sinus Massage test, and Drugs Administration test. Includes tablet for patient instructions and video recording capability during tests.
• Advanced Hemodynamics (HD) Software application enabling 18 cardiovascular parameters including Cardiac Output, Stroke Volume, Systemic Vascular Resistance, Cardiac contractility, Baroreceptor Sensitivity, and others. Uses the Modelflow algorithm to compute hemodynamic parameters from the finger arterial pressure waveform.
• Autonomic Testing (AT) Software application enabling Heart Rate Variability (HRV) parameters and Baroreceptor Sensitivity (BRS) on Finapres NOVA with ECG module. Provides time-domain and frequency-domain HRV parameters including VLF, LF, HF, RMSDD, SDNN, pNN50, and HRVI, using the cross-correlation xBRS method.
• NOVA Measurement Review / NOVAscope Measurement review functionality available on the NOVA device in Review Mode and as a PC application (NOVAscope) for Windows. Enables full measurement review, adding markers and comments, report generation, and data export, including beat-to-beat and raw data export and PDF reporting.
• Remote Control Software Software enabling full remote control of Finapres NOVA via computer or tablet. Supports multiple NOVA devices connected to one computer or multiple computers connected to one NOVA. Connection via existing network or direct Ethernet cable.
• HL7 Connect Healthcare integration software enabling Finapres NOVA to communicate within hospital networks via HL7 V2 standard. Allows exchange of patient and appointment information with Electronic Patient Records and transmission of PDF reports back to the EPR system.
• NANO CORE Module Wrist-worn module introduced in 2016 containing the complete servo-control system including electronics, sensors, valves, signal calculations, and data transfer. All Finapres technology is integrated into the wrist module for the Finapres NOVA.
• Height Correction Unit (HCU) Unit enabling arm movements during measurements by compensating for vertical movement of the hand relative to heart level. Consists of liquid-filled tube connected to pressure transducer at heart level with the finger cuff at the other end, essential for Head-Up Tilt tests and Active Stand tests.
• Finapres Service and Calibration Contract Annual service contract with yearly check and calibration recommended for all Finapres devices, with repair services performed in the Finapres company laboratory.

Quantifiable outcome

• Over 2,500 peer-reviewed publications validating Finapres technology
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature6 records

Partnerships

18 partnerships are on record, tiered core, flagship and regional.

• Demcon GroupcoreStrategic or Co-development PartnerFinapres is an associated company of Demcon, a developer, producer, and supplier of high-end medical equipment solutions. The collaboration led to the next generation of non-invasive hemodynamic monitoring devices including the Finapres NOVA. Finapres became part of the Demcon group in 2011.
• NASAflagshipStrategic or Co-development PartnerNASA has used Finapres devices for hemodynamic research. The portable Portapres device enables research on the ground, in-flight missions, and during extended stays in space. NASA was involved in launching the space version of Portapres in 1995 along with ESA and CNES.
• ESA (European Space Agency)flagshipStrategic or Co-development PartnerESA partnered with Finapres for space research applications. The space version of Portapres was launched in 1995 in collaboration with ESA and CNES for hemodynamic monitoring during space missions.
• CNES (Centre National d'Etudes Spatiales)flagshipStrategic or Co-development PartnerFrench space agency CNES collaborated on the development of the space version of Portapres in 1995 along with ESA and NASA for physiological experiments during space missions.
• Smart Medical Ltd.coreChannel Partner/ Reseller/ DistributorUK & Ireland distributor for Finapres products. Contact: Mr. Phillip Collins, Cotswold Business Village, Moreton-in-Marsh, Gloucestershire, GL56 0JU United Kingdom.
• ADInstruments Inc.coreChannel Partner/ Reseller/ DistributorUSA distributor for Finapres products. Contact: Lucas Tigges, 4360 Arrowswest Drive, Colorado Springs CO 80907, USA.
• MedTach InccoreChannel Partner/ Reseller/ DistributorCanada distributor for Finapres products. Contact: Mr. Greig Findley, 4145 North Service Rd., Suite 200, Burlington, Ontario, Canada L7L 6A3.
• Life Systems Medical Pty LtdcoreChannel Partner/ Reseller/ DistributorAustralia distributor for Finapres products. Contact: Shannon Tolley, Gladstone Street 188, South Melbourne VIC 3205, Australia.
• Cardion s.r.o.regionalChannel Partner/ Reseller/ DistributorCzech Republic distributor. Contact: Jakub Stritecky, Rybnicka 136, 634 00 Brno, Czech Republic.
• CardionetregionalChannel Partner/ Reseller/ DistributorFrance distributor. Contact: Regis Andrieu, Chemin de Chilly 15, 91160 Champlan, France.
• Biosense SAregionalChannel Partner/ Reseller/ DistributorGreece distributor. Contact: Mr. Artemis Kostaki, Sisini 8, 115 28 Athens, Greece.
• SparkBioregionalChannel Partner/ Reseller/ DistributorItaly distributor. Contact: Enrico Altini, Via Caselle 76, 40068 San Lazzaro di Savena, Bologna, Italy.
• Reynolds Medical sp. z.o.o.regionalChannel Partner/ Reseller/ DistributorPoland distributor. Contact: Mr. Maciej Warda, ul. Renesansowa 5A, 01-905 Warszawa, Poland.
• Octopus LimedicregionalChannel Partner/ Reseller/ DistributorSweden & Norway distributor. Contact: Jan Andersen, Hagernasvagen 10, 183 60 Taby, Sweden.
• Vital Bio-Systems Pvt. Ltd.regionalChannel Partner/ Reseller/ DistributorIndia & Sri Lanka distributor. Contact: Mr. D. Shanthakumar, A1/913, 1st Main Road, Mogappair Eri Scheme, Chennai 600037, India.
• Danmedik Sdn. Bhd.regionalChannel Partner/ Reseller/ DistributorMalaysia distributor. Contact: Daniel Chan, No.9-1, Block E2, Dataran Prima, Jalan PJU 1/42a, Petaling Jaya, 47301 Selangor Darul Ehsan, Malaysia.
• ONSE Medical Inc.regionalChannel Partner/ Reseller/ DistributorSouth Korea distributor. Contact: Suk-Hoan Choi, Marketing Manager, 11 Nonhyeon-ro 158-gil, Gangnam-gu, Seoul 135-893, South Korea.
• G. Barco S.A.regionalChannel Partner/ Reseller/ DistributorColombia distributor. Contact: Calle 99 # 14 - 76 Piso 2, Bogota, Colombia.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• GE HealthCare (Patient Monitoring): Seller of CARESCAPE multi-parameter monitors and a broad portfolio of vital-signs devices in hospitals and clinical research environments. Overlaps with Finapres in clinical-grade BP and cardiac-output monitoring as part of a much wider monitoring portfolio.
• Edwards Lifesciences: Global leader in hemodynamic monitoring via its FloTrac/Vigileo and ClearSight systems, including non-invasive finger-cuff technology acquired from CNSystems. Overlaps with Finapres in continuous BP and cardiac output but serves a much broader perioperative and critical-care installed base.
• Omron Healthcare: Global leader in home and clinical blood-pressure monitors including 24-hour ambulatory devices. Competes with Finapres in the BP monitoring category but focuses on intermittent cuff measurements rather than continuous beat-to-beat hemodynamic monitoring.
• Philips (Patient Monitoring): Major OEM of multi-parameter patient monitors (IntelliVue) used in ICUs and step-down units worldwide, where Finapres NOVA can be a complementary specialty tool for beat-to-beat BP and autonomic testing. Comparable at the level of vital-signs monitoring category rather than product.
• Mindray: Large Chinese medical-device OEM offering multi-parameter patient monitors with continuous non-invasive BP options. Comparable as a high-volume, lower-cost incumbent in vital-signs monitoring across emerging and developed markets where Finapres also distributes.
• Drägerwerk: Manufacturer of ICU and anesthesia patient monitors (Infinity, Perseus) integrated into hospital networks. Competes indirectly with Finapres for hemodynamic-monitoring budgets in critical care, with HL7/EHR interoperability similar to Finapres HL7 Connect.

Others

• ADInstruments: Research-grade physiology data-acquisition platform (PowerLab, LabChart) widely used alongside Finapres hardware in cardiovascular research labs. Listed as Finapres's US distributor; comparable as an ecosystem participant serving the same cardiovascular-research buyer.

Direct peers

• CNSystems Medizintechnik: Austrian developer of the CNAP non-invasive continuous hemodynamic monitoring platform based on finger-cuff and vascular unloading technology. Directly comparable to Finapres NOVA in product category, target users (clinicians and researchers), and continuous beat-to-beat BP/cardiac output use cases.
• Tensiomed: Hungarian developer of non-invasive arterial stiffness and hemodynamic assessment devices (Arteriograph, TensioClinic) used in vascular research and clinical practice. Directly comparable niche player focused on non-invasive hemodynamic parameters in cardiology and vascular medicine.

Emerging players

• iXensor (PixoHealth): Digital-health innovator developing smartphone-based BP and cardiometabolic monitoring. Comparable as an emerging participant in continuous/cuffless blood-pressure measurement that could intersect with Finapres's autonomic-care use cases over time.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/finapres
• LinkedInlinkedin.com/company/finapes

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Finapres Medical Systems